Highlights Roche Holding AG Swiss Exchange

Equities

ROG

CH0012032048

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 09:00:15 21/04/2026 BST			5-day change	1st Jan Change
318.80 ^CHF	-0.65%		+1.17%	-3.14%

08:50am	Roche Announces FDA Acceptance of Application for Gazyva Gazyvaro for Treatment of Systemic Lupus Erythematosus	CI
07:16am	The irresistible pull of AI

Highlights

08:50am	Roche Announces FDA Acceptance of Application for Gazyva Gazyvaro for Treatment of Systemic Lupus Erythematosus	CI
07:16am	The irresistible pull of AI
06:27am	Roche Flags US FDA's Acceptance of License Application for Systemic Lupus Erythematosus Drug	MT
04-20	The Return of TINA
04-16	Swiss Market Index Extends Losses; Barry Callebaut Plummets	MT
04-16	Roche to Buy Cancer-focused Saga Diagnostics for Up to $595 Million	MT
04-16	Roche launches new Elevidys study after feedback from European regulator	RE
04-13	Roche Receives CE Mark for New Elecsys NfL Blood Test to Detect Neuroinflammation in Multiple Sclerosis	CI
04-13	Roche's Elecsys NfL Blood Test Gets CE Mark for Neuroinflammation Detection in Multiple Sclerosis	MT
04-13	Roche receives CE Mark for new Elecsys Nfl blood test to detect neuroinflammation in multiple sclerosis	RE
04-10	Lineage Cell Therapeutics, Inc. Announces Allogeneic Cell Platform Expands into Islet Therapy for Type 1 Diabetes	CI
04-09	C4 Therapeutics, Inc. Enters into New Collaboration Agreement with Roche	CI
04-09	C4 Therapeutics Expands Roche Partnership to Develop Degrader-Antibody Conjugates Against Cancer	MT
03-30	Swiss Market Index Joins European Rally, Shrugs Off Downcast Economic Growth Outlook	MT
03-30	Biogen gets FDA approval for higher dose of genetic disorder drug	RE
03-30	Roche Launches the Cobas MPX-E Assay, A New 4-In-1 Donor Screening Test	CI
03-30	Roche launches the cobas mpx-e assay	RE
03-29	China's Hansoh Pharmaceutical Group beats net profit expectations in 2025	RE
03-27	AstraZeneca Maintained at Buy as BofA Notes Positive Tozorakimab Late-stage Data	MT
03-27	Pharma Mar receives positive opinion from EMA recommending approval of Zepzelca with atezolizumab	RE
03-27	Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion -- Update	DJ
03-26	Disc Medicine Announces Completion of Enrollment of Phase 3 Apollo Trial of Bitopertin in Erythropoietic Protoporphyria	CI
03-25	EirGenix, Sandoz Sign Patent Deal for Breast Cancer Drug in US, Europe	MT
03-24	Roche Launches the Cobas Eplex Respiratory Pathogen Panel 3	CI
03-23	Chugai Pharmaceutical Co., Ltd. Announces Discontinuation Of Development Of GYM329 In Spinal Muscular Atrophy And Facioscapulohumeral Muscular Dystrophy	CI